trigonelline has been researched along with Parkinsonian Disorders in 2 studies
trigonelline: in hydra among other organisms; RN given refers to hydroxide inner salt; structure
N-methylnicotinic acid : A pyridinium ion consisting of nicotinic acid having a methyl substituent on the pyridine nitrogen.
N-methylnicotinate : An iminium betaine that is the conjugate base of N-methylnicotinic acid, arising from deprotonation of the carboxy group.
Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
Excerpt | Relevance | Reference |
---|---|---|
"The rotenone was injected through intracerebroventricular route into substantia nigra pars compacta (SNpc) to induce PD-like manifestations in the male rats." | 1.56 | Naringin Exhibits Neuroprotection Against Rotenone-Induced Neurotoxicity in Experimental Rodents. ( Agrawal, N; Garabadu, D, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Garabadu, D | 1 |
Agrawal, N | 1 |
Gaur, V | 1 |
Bodhankar, SL | 1 |
Mohan, V | 1 |
Thakurdesai, PA | 1 |
2 other studies available for trigonelline and Parkinsonian Disorders
Article | Year |
---|---|
Naringin Exhibits Neuroprotection Against Rotenone-Induced Neurotoxicity in Experimental Rodents.
Topics: Alkaloids; Animals; Dopamine; Drug Evaluation, Preclinical; Electron Transport Chain Complex Protein | 2020 |
Neurobehavioral assessment of hydroalcoholic extract of Trigonella foenum-graecum seeds in rodent models of Parkinson's disease.
Topics: Administration, Oral; Alkaloids; Animals; Antiparkinson Agents; Chromatography, High Pressure Liquid | 2013 |